- Home
- OBIO vs ACR Comparison
OBIO vs ACR Comparison
Compare OBIO & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- ACR
- Stock Information
- Founded
- OBIO 2017
- ACR 2005
- Country
- OBIO United States
- ACR United States
- Employees
- OBIO N/A
- ACR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- ACR Real Estate Investment Trusts
- Sector
- OBIO Health Care
- ACR Real Estate
- Exchange
- OBIO Nasdaq
- ACR Nasdaq
- Market Cap
- OBIO 172.1M
- ACR 143.3M
- IPO Year
- OBIO N/A
- ACR N/A
- Fundamental
- Price
- OBIO $4.00
- ACR $19.24
- Analyst Decision
- OBIO Strong Buy
- ACR Buy
- Analyst Count
- OBIO 4
- ACR 2
- Target Price
- OBIO $14.00
- ACR $23.50
- AVG Volume (30 Days)
- OBIO 351.1K
- ACR 17.7K
- Earning Date
- OBIO 11-11-2025
- ACR 10-29-2025
- Dividend Yield
- OBIO N/A
- ACR N/A
- EPS Growth
- OBIO N/A
- ACR N/A
- EPS
- OBIO N/A
- ACR 0.04
- Revenue
- OBIO $2,944,000.00
- ACR $86,599,000.00
- Revenue This Year
- OBIO $29.26
- ACR $7.03
- Revenue Next Year
- OBIO $10.65
- ACR $3.26
- P/E Ratio
- OBIO N/A
- ACR $422.79
- Revenue Growth
- OBIO 41.61
- ACR 12.74
- 52 Week Low
- OBIO $2.20
- ACR $14.87
- 52 Week High
- OBIO $6.50
- ACR $23.81
- Technical
- Relative Strength Index (RSI)
- OBIO 67.99
- ACR 33.83
- Support Level
- OBIO $3.53
- ACR $18.99
- Resistance Level
- OBIO $4.04
- ACR $20.80
- Average True Range (ATR)
- OBIO 0.33
- ACR 0.48
- MACD
- OBIO 0.07
- ACR -0.15
- Stochastic Oscillator
- OBIO 94.20
- ACR 12.69
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.